Literature DB >> 16353132

Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutated.

Megumi Yoshida1, Mitsukuni Okabe, Tadaaki Eimoto, Shinichiro Shimizu, Kayo Ueda-Otsuka, Masataka Okamoto, Genichiro Ishii, Ryuzo Ueda, John K C Chan, Shigeo Nakamura, Hiroshi Inagaki.   

Abstract

Thymic MALT lymphoma shows certain distinctive features among MALT lymphomas, such as expression of IgA isotype, consistent lack of API2-MALT1 gene fusion, and very strong association with autoimmune disease, especially Sjogren's syndrome. To help clarify the nature of the clonal lymphoid infiltrates, we analysed the usage and somatic hypermutation of the Ig heavy chain variable region (V(H)) genes in nine different cases. The V(H) rearrangement was potentially functional in all cases and was restricted to the V(H)3 family. V(H) usage was biased toward V(H)3-30 (five cases) and V(H)3-23 (three cases) segments, which have both been frequently expressed by autoimmune B cells. Somatic hypermutation was absent in five cases. Fewer than the expected replacement mutations were found in the framework regions in two cases, indicating a negative antigen selection pressure. Ongoing mutation was absent in all cases. D segment usage was varied, whereas J(H) segment usage was restricted to J(H)4. The observed patterns of V(H) usage and mutations suggested that specific antigens may play a pathologically relevant role in the genesis or progression of thymic MALT lymphoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16353132     DOI: 10.1002/path.1889

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Differences in Vitreous Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Ranibizumab Treatment.

Authors:  Xinping She; Chen Zou; Zhi Zheng
Journal:  Front Med (Lausanne)       Date:  2022-05-27

2.  Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.

Authors:  Magali Colombat; Hervé Mal; Christiane Copie-Bergman; Jacques Diebold; Diane Damotte; Patrice Callard; Michel Fournier; Jean-Pierre Farcet; Marc Stern; Marie-Hélène Delfau-Larue
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

3.  MALT lymphoma of the thymus with Sjögren's syndrome: biphasic changes in serological abnormalities over a 4-year period following thymectomy.

Authors:  Takashi Sakamoto; Kouhei Yamashita; Chisaki Mizumoto; Maki Ueda; Tomoharu Takeoka; Terutoshi Hishita; Shigefusa Hada; Tatsuharu Ohno
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

Review 4.  [Primary thymic mucosa-associated lymphoid tissue lymphoma: 7 clinical cases report and a review of the literature].

Authors:  D M Xu; L Wang; H Y Zhu; J H Liang; J Y Li; W Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

5.  MALT1 regulates Th2 and Th17 differentiation via NF-κB and JNK pathways, as well as correlates with disease activity and treatment outcome in rheumatoid arthritis.

Authors:  Qiubo Wang; Yapeng Wang; Qingyang Liu; Ying Chu; Rui Mi; Fengying Jiang; Jingjing Zhao; Kelong Hu; Ran Luo; Yufeng Feng; Harrison Lee; Dong Zhou; Jingyi Mi; Ruoyu Deng
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

6.  A systematic review and meta-analysis of thymic mucosa-associated lymphoid tissue lymphoma.

Authors:  Meng-Xin Zhou; Ye-Ye Chen; Jia-Qi Zhang; Wen-Liang Bai; Cheng Huang; Chao Guo; Hong-Sheng Liu; Shan-Qing Li
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.